PSTV
Plus Therapeutics·NASDAQ
--
--(--)
--
--(--)
9.22 / 10
Outperform
Analyst view is overwhelmingly bullish: one Strong Buy (100%) from Jason Kolbert, though his historical win rate is 37.5% with –3.36% average return. Fund‑flow rating is good (7.83), overall inflow positive, but small and large block patterns show slight negative trends.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-19
InstitutionD. Boral Capital
Times predicted16
Historical Win Rate37.5%
What is the analyst consensus for PSTV?
- PSTV holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 9.22/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
